德国马尔堡菲利普斯大学招聘分子肿瘤方向博士后
At the Faculty of Medicine, Institute of Molecular Biology and Tumor Research (IMT), Research Group
Molecular Oncology, Prof. Dr. Thorsten Stiewe, we offer the following position for a period of 3 years, with optional prolongation, two third-party funded:
Scientific Employee (Postdoctoral Position)
Salary and benefits are according to a public service position in Germany (TV-H), pay scale E 13, and
commensurate with experience. The positions are available immediately (100 % of regular working hours) and will offer the possibility of further scientific qualification in the frame of the assigned duties.
The Institute of Molecular Biology and Tumor Research (IMT) is an international research institute dedicated to unravel the molecular mechanisms underlying the development of cancer and to establish novel therapeutic concepts. The Molecular Oncology Research Group focuses on basic science and translational research related to the p53 family of tumor suppressor genes. In particular, we aim to understand how the p53 transcription factor specifically recognizes target genes in the context of a complex genome to selectively activate tumor suppressive effector programs such as apoptosis or senescence in a stimulus-dependent manner. The aim of the projects will be to study the regulation of p53 at the level of chromatin and DNA binding. Apart from classical biochemical and molecular biology techniques, the group holds state-of-the-art equipment for genome-wide analyses such as next generation sequencing, microarrays, and RNAi screening. The research group is located in the new Center for Tumor- and Immunobiology housing highend
core facilities for flow cytometry, microscopy, small animal imaging (MRI, PET-SPECT), and bioinformatics.
Our research is funded by the European Research Council (ERC), German Research Foundation (DFG) and German Cancer Aid (Deutsche Krebshilfe) and embedded into the stimulating research environment provided by local collaborative research structures such as the SFB/TRR81 "Chromatin changes in differentiation and malignancies" and the KFO210 "Genetics of drug resistance in cancer".
Required are a PhD degree and a strong scientific background in transcriptional regulation or cancer research. We are looking for talented scientists driven by the desire to make a relevant contribution to the field of cancer
biology.